Overview
Survival Analysis
Causal Inference
Design and Analysis of Clinical Trials
Methods for Diagnostic and Predictive Medicine
Analysis of Data from Multiple Sources
Causal Inference
Design and Analysis of Clinical Trials
Methods for Diagnostic and Predictive Medicine
Analysis of Data from Multiple Sources
Current Appointments & Affiliations
Professor of Biostatistics & Bioinformatics
·
2021 - Present
Biostatistics & Bioinformatics, Division of Biostatistics,
Biostatistics & Bioinformatics
Member of the Duke Cancer Institute
·
2015 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
The design of a small Bayesian hybrid-controlled trial utilizing time-to-event data from six published sources that used best alternative care to treat liver-predominant metastasis from primary ocular melanoma
Journal Article Contemporary Clinical Trials Communications · June 2026 Full text CiteMature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
Journal Article Int J Radiat Oncol Biol Phys · May 3, 2026 PURPOSE: We report mature outcomes of patients with limited-stage small cell lung cancer randomly assigned to the 61.2 Gy concomitant boost (CB) thoracic radiation therapy (TRT) arm of Cancer and Leukemia Group B (CALGB) 30610/Radiation Therapy Oncology Gr ... Full text Link to item CiteCHIO3: CHemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B (N2) Non-Small cell lung cancer (AFT-46).
Journal Article Lung Cancer · May 2026 BACKGROUND: Despite a deluge of perioperative non-small cell lung cancer (NSCLC) checkpoint inhibitor trials, none have looked exclusively at an N2+ population. This trial focused on operable N2+ NSCLC and uniquely sought to evaluate N2 nodal clearance (N2 ... Full text Link to item CiteRecent Grants
AFT-61 Stats
ResearchPrincipal Investigator · Awarded by Alliance Foundation Trials, LLC · 2025 - 2030AFT-57 Trials (5d)
ResearchPrincipal Investigator · Awarded by Alliance Foundation Trials, LLC · 2023 - 2028Methods to improve efficiency and robustness of clinical trials using information from real-world data with hidden bias
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2023 - 2026View All Grants
Education
University of North Carolina, Chapel Hill ·
2003
Ph.D.